Ford CEO Jim Farley says that a culture change at the automaker lead to Ford becoming a "four-year overnight success." Farley also says American workers are beating the likes of Toyota and Hyundai in terms of vehicle quality. Farley spoke with Bloomberg's Matthew Miller.
Apple is raising prices on several products to offset cost hikes caused by a shortage of memory chips and storage. Prices are going up for the MacBook Neo, MacBook Pro, MacBook Air, iPad Air and iPad Pro. Price hikes are global and vary by product.
US consumer spending accelerated in May even as prices rose at the fastest pace in more than three years. Inflation-adjusted consumer spending rose 0.3% from a month earlier. The personal consumption expenditures price index rose 4.1% last month from a year earlier. Enda Curran reports.
Kroger (NYSE:KR) announced that its Board of Directors approved an 11% increase in the annual dividend from $1.40 to $1.56 per share.
HUTCHMED (NASDAQ:HCM) reported pivotal Phase II data for fanregratinib in pretreated advanced intrahepatic cholangiocarcinoma, with an IRC-assessed objective response rate of 42.5%.
MIRA Pharmaceuticals (NASDAQ:MIRA) reported new preclinical data for Mira-55, its cannabinoid analog candidate for the treatment of chronic inflammatory pain.
Bill Dudley, former New York Fed President and Bloomberg Opinion columnist, says streamlining the Federal Open Market Committee's policy statement is appropriate, but Federal Reserve Chairman Kevin Warsh needs to make changes with greater care than he has shown to date. Dudley says Warsh may risk confusing markets and the central bank itself. His opinions are his own.
GE Aerospace (NYSE:GE) declared a quarterly dividend of $0.47 per share on its outstanding common stock.
Nano-X Imaging (NASDAQ:NNOX) reported Q1 2026 revenue of $4.3 million, up from $2.8 million a year earlier, while net loss reached $14.3 million.
Sunshine Biopharma (NASDAQ:SBFM) received Canadian regulatory approval for its 1mg generic Anastrozole tablets, the equivalent of Arimidex.
Agilent Technologies (NYSE:A) completed its previously announced $950 million acquisition of Biocare Medical, adding the clinical pathology company to its Life Sciences and Diagnostics Markets Group.
Virtuix (NASDAQ:VTIX) reported fiscal 2026 net sales of $4.3 million, an increase of 18% from the prior year.
_1428170_640x360_2504724547519-640x360.webp&w=3840&q=75)
_1428132_640x360_2504723523616-640x360.webp&w=3840&q=75)
_1428124_640x360_2504724035534-640x360.webp&w=3840&q=75)
_1428095_640x360_2504720451552-640x360.webp&w=3840&q=75)
